News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
729,840 Results
Type
Article (43183)
Company Profile (300)
Press Release (686344)
Multimedia
Podcasts (100)
Webinars (17)
Section
Business (210796)
Career Advice (2099)
Deals (36699)
Drug Delivery (111)
Drug Development (83320)
Employer Resources (175)
FDA (16709)
Job Trends (15466)
News (356917)
Policy (34081)
Tag
Academia (2602)
Accelerated approval (14)
Adcomms (24)
Allergies (113)
Alliances (51641)
ALS (128)
Alzheimer's disease (1532)
Antibody-drug conjugate (ADC) (178)
Approvals (16760)
Artificial intelligence (372)
Autoimmune disease (40)
Automation (23)
Bankruptcy (372)
Best Places to Work (11770)
BIOSECURE Act (20)
Biosimilars (138)
Biotechnology (188)
Bladder cancer (111)
Brain cancer (43)
Breast cancer (412)
Cancer (3331)
Cardiovascular disease (279)
Career advice (1767)
Career pathing (33)
CAR-T (205)
CDC (38)
Cell therapy (552)
Cervical cancer (27)
Clinical research (69084)
Collaboration (1208)
Company closure (4)
Compensation (840)
Complete response letters (42)
COVID-19 (2732)
CRISPR (72)
C-suite (480)
Cystic fibrosis (124)
Data (3666)
Decentralized trials (2)
Denatured (32)
Depression (81)
Diabetes (386)
Diagnostics (6570)
Digital health (27)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (166)
Drug pricing (152)
Drug shortages (31)
Duchenne muscular dystrophy (172)
Earnings (90251)
Editorial (45)
Employer branding (21)
Employer resources (151)
Events (117524)
Executive appointments (910)
FDA (18859)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1051)
Gene editing (153)
Generative AI (26)
Gene therapy (442)
GLP-1 (881)
Government (4706)
Grass and pollen (6)
Guidances (331)
Healthcare (19042)
HIV (42)
Huntington's disease (32)
IgA nephropathy (49)
Immunology and inflammation (194)
Immuno-oncology (13)
Indications (46)
Infectious disease (2925)
Inflammatory bowel disease (166)
Inflation Reduction Act (10)
Influenza (77)
Intellectual property (157)
Interviews (324)
IPO (16883)
IRA (55)
Job creations (4070)
Job search strategy (1495)
Kidney cancer (13)
Labor market (63)
Layoffs (547)
Leadership (23)
Legal (8414)
Liver cancer (84)
Longevity (12)
Lung cancer (481)
Lymphoma (245)
Machine learning (21)
Management (59)
Manufacturing (515)
MASH (110)
Medical device (13641)
Medtech (13658)
Mergers & acquisitions (20616)
Metabolic disorders (963)
Multiple sclerosis (110)
NASH (18)
Neurodegenerative disease (156)
Neuropsychiatric disorders (39)
Neuroscience (2356)
NextGen: Class of 2025 (6643)
Non-profit (4540)
Now hiring (53)
Obesity (477)
Opinion (257)
Ovarian cancer (111)
Pain (150)
Pancreatic cancer (142)
Parkinson's disease (200)
Partnered (24)
Patents (367)
Patient recruitment (260)
Peanut (54)
People (60012)
Pharmaceutical (90)
Pharmacy benefit managers (23)
Phase I (21388)
Phase II (30375)
Phase III (22763)
Pipeline (2390)
Policy (243)
Postmarket research (2683)
Preclinical (9128)
Press Release (68)
Prostate cancer (161)
Psychedelics (41)
Radiopharmaceuticals (261)
Rare diseases (542)
Real estate (6280)
Recruiting (68)
Regulatory (23993)
Reports (51)
Research institute (2382)
Resumes & cover letters (359)
Rett syndrome (11)
RNA editing (12)
RSV (55)
Schizophrenia (114)
Series A (173)
Series B (130)
Service/supplier (12)
Sickle cell disease (71)
Special edition (21)
Spinal muscular atrophy (151)
Sponsored (35)
Startups (3746)
State (2)
Stomach cancer (15)
Supply chain (87)
Tariffs (80)
The Weekly (66)
Vaccines (889)
Venture capital (59)
Weight loss (306)
Women's health (51)
Worklife (17)
Date
Today (112)
Last 7 days (428)
Last 30 days (2223)
Last 365 days (31359)
2025 (21823)
2024 (35776)
2023 (40639)
2022 (51807)
2021 (56340)
2020 (54797)
2019 (47414)
2018 (35780)
2017 (33156)
2016 (32671)
2015 (38639)
2014 (32559)
2013 (27685)
2012 (29774)
2011 (30515)
2010 (28525)
Location
Africa (791)
Alabama (69)
Alaska (7)
Arizona (265)
Arkansas (14)
Asia (41375)
Australia (6610)
California (8551)
Canada (2649)
China (794)
Colorado (357)
Connecticut (364)
Delaware (226)
Europe (88751)
Florida (1276)
Georgia (285)
Hawaii (2)
Idaho (60)
Illinois (695)
India (40)
Indiana (408)
Iowa (17)
Japan (265)
Kansas (114)
Kentucky (31)
Louisiana (16)
Maine (65)
Maryland (1139)
Massachusetts (6305)
Michigan (266)
Minnesota (507)
Mississippi (4)
Missouri (101)
Montana (28)
Nebraska (25)
Nevada (98)
New Hampshire (68)
New Jersey (2344)
New Mexico (29)
New York (2325)
North Carolina (1210)
North Dakota (8)
Northern California (3867)
Ohio (261)
Oklahoma (17)
Oregon (40)
Pennsylvania (1811)
Puerto Rico (17)
Rhode Island (41)
South America (1166)
South Carolina (44)
South Dakota (1)
Southern California (3281)
Tennessee (138)
Texas (1320)
United States (31270)
Utah (254)
Virginia (221)
Washington D.C. (74)
Washington State (712)
West Virginia (4)
Wisconsin (74)
729,840 Results for "boehringer ingelheim pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Boehringer Ingelheim Launches Swine Vaccine With Advanced Protection Against Porcine Circovirus Type 2 in the United States
September 4, 2025
·
4 min read
Press Releases
Boehringer Ingelheim Celebrates Next Generation of Biomedical Researchers at 2025 Veterinary Scholars Symposium
August 12, 2025
·
5 min read
Venture capital
Building Pharma’s Farm System: Eli Lilly, Boehringer Ingelheim, More Invest in the Future
While a substantial portion of pipeline assets are externally sourced, many Big Pharmas are tapping into incubators and venture funds to uncover cutting-edge scientific trends, determine their future focus points and even carve out a niche in an emerging geographical hotspot.
August 6, 2025
·
5 min read
·
Heather McKenzie
Lung cancer
140-Year-Old Boehringer Ingelheim Dives Into Cancer With NSCLC Nod
Phase Ib data show Hernexeos can elicit a confirmed objective response rate of 44% in patients with HER2-mutated NSCLC who had previously been treated with a directed antibody-drug conjugate.
August 11, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Boehringer Ingelheim Harnesses GenAI to Transform Case Intake with LifeSphere® NavaX™
July 8, 2025
·
2 min read
Press Releases
Boehringer Ingelheim and Eko Health Inc. enter digital health collaboration to improve heart murmur detection in dogs
June 10, 2025
·
4 min read
Press Releases
Boehringer Ingelheim and Palatin Technologies to develop potential first-in-class melanocortin receptor targeted treatment for patients with retinal diseases
August 19, 2025
·
6 min read
Press Releases
Boehringer Ingelheim and Re-Vana Therapeutics Announce Strategic Collaboration to Develop Long-Acting Ophthalmic Therapies
July 29, 2025
·
4 min read
Collaboration
Boehringer Ingelheim Expands Cancer Pipeline With Back-to-Back Antibody Deals
On Thursday, Boehringer Ingelheim announced a partnership with Synaffix to advance antibody-drug conjugates and exercised its fourth license option under a 2013 collaboration with Oxford BioTherapeutics.
January 10, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Boehringer Ingelheim Pharmaceuticals, Inc. Welcomes Brian Hilberdink as President, U.S. Human Pharma
February 20, 2025
·
2 min read
1 of 72,984
Next
